Sepsis News and Research

Latest Sepsis News and Research

Effect of hydrocortisone treatment modality on glycemic control in patients with septic shock

Changing how critically ill patients are treated with hydrocortisone could reduce hyperglycemia.

18 Feb 2007

Early feeding could help reduce liver dysfunction in critically ill patients

Changing the way that critically ill patients suffering from sepsis or multiple organ failure are fed could reduce liver dysfunction.

25 Jan 2007

How to save a million lives a year

A promise of $200 million from some of the world's richest nations to fight diseases in poor countries will save more than a million children's lives a year.

1 Dec 2006

Check out hospital rating before checking in

According to the latest study, the gap between the best and worst performing hospitals in the United States has widened by as much as 5 percent since last year.

17 Oct 2006

Drug trial fiasco induced immune system overload in patients

The doctors who treated six British men in a trial of a drug in March which went horribly wrong, say they believe the men suffered an immune system overreaction known as a cytokine storm.

15 Aug 2006

New treatment for septic shock

A potential new treatment for septic shock and other inflammatory diseases has been discovered by Monash Institute researchers.

14 Aug 2006

New group B strep test for newborn babies approved

The Food and Drug Administration on Tuesday approved a new test studied at the University of Florida that could lead to better screening for the most common cause of infection in newborn babies.

27 Jul 2006

Conjugate vaccines for preventing meningococcal C meningitis and septicaemia

A new systematic review suggests that a certain kind of vaccine may help to protect babies and small children from a devastating killer: meningococcal meningitis.

19 Jul 2006

Arthritis drug wins approval for use in children with Crohn's disease

The Food and Drug Administration in the U.S. has given approval for the drug Remicade for use in children with active Crohn's disease(CD), a chronic and debilitating condition.

21 May 2006

Inducing labor increases risk of developing chorioamnionitis

Women who have their labor induced or are given medication to stimulate contractions are at greater risk of developing chorioamnionitis

16 May 2006

Method by which Caspase-12 shuts down the body's immune system discovered

Caspase-12 is a molecule with a death-wish. Found only in people of African descent, this protein shuts down our body's immune system, opening the door to potentially lethal infections. In a groundbreaking new study published in the prestigious journal Nature this week, the team that first discovered the role of caspase-12 in humans has now uncovered the mechanism by which it sabotages us, allowing researchers to develop methods to counter its damaging effects.

28 Apr 2006

Caspase-12 antagonists could potentially be useful in the treatment of sepsis and other inflammatory and immune disorders

According to the new study, the presence of caspase-12, which appears to modulate inflammation and innate immunity in humans, increases the body's "vulnerability to bacterial infection and septic shock" while a deficiency confers strong resistance to sepsis. This new discovery suggests that caspase-12 antagonists could be a potentially useful in the treatment of sepsis and other inflammatory and immune disorders.

26 Apr 2006

Corticosteroids do not improve survival in patients with late-stage acute respiratory distress syndrome

The study is the first multi-center randomized clinical trial to evaluate the effects of moderate doses of steroids in ARDS patients when treatment is started 7 days or more after the onset of the condition.

20 Apr 2006

FDA investigates abortion pill death

It seems that since the FDA approved the use of the abortion pill RU-486, (Mifeprex/ mifepristone) in September 2000, six women in the U.S. have died.

12 Apr 2006

Similarities and differences in outcomes of cirrhosis due to nonalcoholic steatohepatitis and hepatitis C

Cirrhosis related to non-alcoholic steatohepatitis (NASH) is associated with fewer complications and a lower mortality compared to cirrhosis from hepatitis C, despite NASH patients' greater risk of dying from cardiovascular events.

11 Apr 2006

Streptococcal toxic shock syndrome caused by Streptococcus suis Serotype 2

Last year, there was major press coverage of an alarmingly large and deadly outbreak of Streptococcus suis disease in Sichuan province in China.

11 Apr 2006

Nrf2 gene findings may offer therapeutic potential for sepsis treatment

Disruption of a single gene, Nrf2, plays a critical role in regulating the body's innate immune response to sepsis and septic shock, according to a study by a research team led by Shyam Biswal, PhD, at the Johns Hopkins Bloomberg School of Public Health.

4 Apr 2006

Hospitalized schizophrenics more likely to have complications

A Johns Hopkins study of more than 1,700 patients with schizophrenia hospitalized for medical or surgical care unrelated to their mental disorder shows they are at least twice as likely as similar patients without schizophrenia to suffer dangerous and expensive adverse events.

15 Mar 2006

Breakthrough in fast, disposable DNA testing

Thermal Gradient announced today that it has successfully developed a 30-cycle PCR device that can amplify DNA in just 4.4 minutes, far faster than anything available in the marketplace.

9 Mar 2006

Breakthrough anti-inflammatory treatment

Scientists from the Garvan Institute of Medical Research have developed what could be the next big blockbuster treatment for inflammatory diseases such as rheumatoid arthritis and asthma.

21 Feb 2006